Bioray Laboratories
Works in Cardiovascular · Dermatology · Genetic & rare · Hematology · Immunology · Musculoskeletal · Neurology · Oncology · Ophthalmology · Renal & urogenital · Women's health
Bioray Laboratories is a clinical trial sponsor. It has 10 active clinical trials with 175 planned participants, across 11 therapeutic areas. Since 2021 it has completed 2 trials and stopped 6 early.
Trial track record · since 2021
Pipeline · 10 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Bioray Laboratories
Bioray Laboratories is lead sponsor of 10 active clinical trials on ClinicalTrials.gov, with 175 planned participants, in Cardiovascular, Dermatology, Genetic & rare, Hematology and other areas. Since 2021 it has completed 2 trials and stopped 6 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Bioray Laboratories; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-21.
Approve Suite is not affiliated with Bioray Laboratories.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.